146 related articles for article (PubMed ID: 19844231)
21. Inhibition of c-MET is a potential therapeutic strategy for treatment of diffuse large B-cell lymphoma.
Uddin S; Hussain AR; Ahmed M; Al-Dayel F; Bu R; Bavi P; Al-Kuraya KS
Lab Invest; 2010 Sep; 90(9):1346-56. PubMed ID: 20531293
[TBL] [Abstract][Full Text] [Related]
22. Expression of BCL-2 proto-oncogene in adult acute lymphoblastic leukemia.
Campos L; Sabido O; Sebban C; Charrin C; Bertheas MF; Fière D; Guyotat D
Leukemia; 1996 Mar; 10(3):434-8. PubMed ID: 8642858
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Index for Nonsmall Cell Lung Cancer Based on Immune-Related Genes Expression.
Cao Y; Zhu H; Shen H; Liu D; Li Z; Shang H; Du H; Wang Y; Ye J
Biomed Res Int; 2022; 2022():4779811. PubMed ID: 36193311
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of HIF-1α in digestive system malignancies: evidence from a systematic review and meta-analysis.
Arjmand MH; Moradi A; Rahimi HR; Es-Haghi A; Akbari A; Hadipanah MR; Afshar J; Mehrad-Majd H
Gastroenterol Hepatol Bed Bench; 2022; 15(2):108-119. PubMed ID: 35845307
[TBL] [Abstract][Full Text] [Related]
25. Phase I Open-Label Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Dilpacimab in Patients with Advanced Solid Tumors.
Gordon MS; Nemunaitis J; Barve M; Wainberg ZA; Hamilton EP; Ramanathan RK; Sledge GW; Yue H; Morgan-Lappe SE; Blaney M; Kasichayanula S; Motwani M; Wang L; Naumovski L; Strickler JH
Mol Cancer Ther; 2021 Oct; 20(10):1988-1995. PubMed ID: 34315767
[TBL] [Abstract][Full Text] [Related]
26. Eosinophil and lymphocyte counts predict bevacizumab response and survival in recurrent glioblastoma.
Vaios EJ; Winter SF; Muzikansky A; Nahed BV; Dietrich J
Neurooncol Adv; 2020; 2(1):vdaa031. PubMed ID: 32642690
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia and Macrophages Act in Concert Towards a Beneficial Outcome in Colon Cancer.
Martins F; Oliveira R; Cavadas B; Pinto F; Cardoso AP; Castro F; Sousa B; Pinto ML; Silva AJ; Adão D; Loureiro JP; Pedro N; Reis RM; Pereira L; Oliveira MJ; Costa AM
Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32231135
[TBL] [Abstract][Full Text] [Related]
28. Increased Expression of Delta-like Ligand 4 in Mycosis Fungoides.
Boki H; Miyagaki T; Shono Y; Kamijo H; Oka T; Suga H; Asano Y; Sugaya M; Sato S
Acta Derm Venereol; 2020 Feb; 100(4):adv00059. PubMed ID: 31930426
[TBL] [Abstract][Full Text] [Related]
29. Inflammation-induced colon cancer in uPA-deficient mice is associated with a deregulated expression of Notch signaling pathway components.
Afaloniati H; Karagiannis GS; Karavanis E; Psarra TA; Karampatzakis-Kouritas A; Poutahidis T; Angelopoulou K
Mol Cell Biochem; 2020 Jan; 464(1-2):181-191. PubMed ID: 31758376
[TBL] [Abstract][Full Text] [Related]
30. High delta-like ligand 4 expression correlates with a poor clinical outcome in gastric cancer.
Kim Y; Byeon SJ; Hur J; Lee K; Kim D; Ahn JH; Lee SH; You WK; Kim ST; Park SH; Kang WK; Kim KM; Lee J
J Cancer; 2019; 10(14):3172-3178. PubMed ID: 31289587
[No Abstract] [Full Text] [Related]
31. Tumor suppressive effects of the pleiotropically acting miR-195 in colorectal cancer cells.
Forouzan Jahromi Z; Javeri A; Fakhr Taha M
EXCLI J; 2019; 18():243-252. PubMed ID: 31217787
[TBL] [Abstract][Full Text] [Related]
32. The PERK Branch of the Unfolded Protein Response Promotes DLL4 Expression by Activating an Alternative Translation Mechanism.
Jaud M; Philippe C; Van Den Berghe L; Ségura C; Mazzolini L; Pyronnet S; Laurell H; Touriol C
Cancers (Basel); 2019 Jan; 11(2):. PubMed ID: 30691003
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Role of Hypoxia-Inducible Factor-2α Tumor Cell Expression in Cancer Patients: A Meta-Analysis.
Moreno Roig E; Yaromina A; Houben R; Groot AJ; Dubois L; Vooijs M
Front Oncol; 2018; 8():224. PubMed ID: 29942795
[TBL] [Abstract][Full Text] [Related]
34. Notch ligand Delta-like 1 as a novel molecular target in childhood neuroblastoma.
Bettinsoli P; Ferrari-Toninelli G; Bonini SA; Prandelli C; Memo M
BMC Cancer; 2017 May; 17(1):352. PubMed ID: 28525978
[TBL] [Abstract][Full Text] [Related]
35. Role of Delta-like 4 in Jagged1-induced tumour angiogenesis and tumour growth.
Oon CE; Bridges E; Sheldon H; Sainson RCA; Jubb A; Turley H; Leek R; Buffa F; Harris AL; Li JL
Oncotarget; 2017 Jun; 8(25):40115-40131. PubMed ID: 28445154
[TBL] [Abstract][Full Text] [Related]
36. Endothelial Dll4 overexpression reduces vascular response and inhibits tumor growth and metastasization in vivo.
Trindade A; Djokovic D; Gigante J; Mendonça L; Duarte A
BMC Cancer; 2017 Mar; 17(1):189. PubMed ID: 28288569
[TBL] [Abstract][Full Text] [Related]
37. Targeting angiogenesis in gastrointestinal tumors: current challenges.
Nandikolla AG; Rajdev L
Transl Gastroenterol Hepatol; 2016; 1():67. PubMed ID: 28138633
[TBL] [Abstract][Full Text] [Related]
38. Integrative analysis of mutational and transcriptional profiles reveals driver mutations of metastatic breast cancers.
Lee JH; Zhao XM; Yoon I; Lee JY; Kwon NH; Wang YY; Lee KM; Lee MJ; Kim J; Moon HG; In Y; Hao JK; Park KM; Noh DY; Han W; Kim S
Cell Discov; 2016; 2():16025. PubMed ID: 27625789
[TBL] [Abstract][Full Text] [Related]
39. The effect of epigenetic silencing and TP53 mutation on the expression of DLL4 in human cancer stem disorder.
Yao Z; Sherif ZA
Oncotarget; 2016 Sep; 7(39):62976-62988. PubMed ID: 27542210
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis.
van Kuijk SJ; Yaromina A; Houben R; Niemans R; Lambin P; Dubois LJ
Front Oncol; 2016; 6():69. PubMed ID: 27066453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
